SPONSOR
Praxis Precision Medicines
Total Trials
3
Recruiting
3
Phases
Phase 3, Phase 2, Phase 3
Praxis Precision Medicines is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Focal Epilepsy, Epileptic Encephalopathy, SCN2A Encephalopathy, Focal Seizure.
The trial portfolio spans Phase 3, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Praxis Precision Medicines
How many clinical trials has Praxis Precision Medicines sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Praxis Precision Medicines, of which 3 are actively recruiting participants. These trials cover conditions including Focal Epilepsy, Epileptic Encephalopathy, SCN2A Encephalopathy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Praxis Precision Medicines research focus on?
Praxis Precision Medicines clinical trials span Focal Epilepsy, Epileptic Encephalopathy, SCN2A Encephalopathy, Focal Seizure. The research pipeline includes Phase 3, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Praxis Precision Medicines clinical trial?
To participate in a Praxis Precision Medicines trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Praxis Precision Medicines trials with current recruitment status updated daily.
Clinical Trials by Praxis Precision Medicines
NCT07505004 Phase 3
Recruiting
Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures
Focal Epilepsy
NCT07019922 Phase 3
Recruiting
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Epileptic Encephalopathy
NCT06999902 Phase 2, Phase 3
Recruiting
Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)
Focal Seizure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology